authors
- Lu, J
- Deng, H
- Tang, R
- Hsu, C
- Kindler, HL
- Fuchs, C
- Gansert, J
- Bray, Steven
- Loh, E
- Zhu, M
Exposure-response (E-R) analysis to facilitate phase III (P3) dose selection for AMG 479 (A479) in combination with gemcitabine (G) to treat metastatic pancreatic cancer (mPC).
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- February 1, 2011
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal